No Data
Express News | Entero Therapeutics Inc: Exploring Strategic Alternatives for Purpose of Maximizing Value of All of Our Stakeholders
Express News | Entero Therapeutics Inc: Have Reduced Headcount and Paused Development Activities
Express News | Entero Therapeutics Inc: Acceleration or Reduction of Cash Outflows and Debt Obligations Can Significantly Impact Our Ability to Maintain Operations
Express News | Entero Therapeutics: On Nov 21, Immunogenx Received Notice of Default, Demand for Payment Relating to Credit Agreement, Dated as of Oct 3, 2022
Entero Therapeutics CEO James Sapirstein to Moderate the 2024 BioFlorida Annual Innovation Conference CEO Forum
Shareholder Alert: Ademi LLP Investigates Whether Entero Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders
AddiBee0925 : Hey Jag. Just a heads up. If all goes as planned, the launch for SIDU and SpaceX is on the schedule for this Friday on the 20th. I wouldn't think that it would be rescheduled so soon to the launch, at least no report has said otherwise.
Jaguar8 OP AddiBee0925 : Yes. But there might be a build up of the price before the launch just like LUNR. Hopefully it goes well.
AddiBee0925 Jaguar8 OP : yeah I'm thinking the same
Jaguar8 OP browny_440 : TNXP will be good if FDA releases decision soon
72306783 : I would like to ask, what signals or standards do you use to start building positions? I am still learning... Thank you very much for your Share
View more comments...